𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel receptor antagonists welcome a new era in endothelin biology

✍ Scribed by S.A. Douglas; E.H. Ohlstein; T.D. Meek

Book ID
116103595
Publisher
Elsevier Science
Year
1994
Tongue
English
Weight
481 KB
Volume
15
Category
Article
ISSN
0165-6147

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

ChemInform Abstract: Synthesis and Struc
ChemInform Abstract: Synthesis and Structureβ€”Activity Relationships in a Series of Ethenesulfonamide Derivatives, a Novel Class of Endothelin Receptor Antagonists.
✍ Hironori Harada; Jun-ichi Kazami; Susumu Watanuki; Ryuji Tsuzuki; Katsumi Sudoh; πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons βš– 30 KB πŸ‘ 2 views

## Abstract ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a ChemInform Abstract of an article which was published elsewhere, please select a β€œFull Text” option. The original article is trackable v

Tezosentan, a novel endothelin receptor
Tezosentan, a novel endothelin receptor antagonist, markedly reduces rat hepatic ischemia and reperfusion injury in three different models
✍ Douglas G. Farmer; Fady Kaldas; Dean Anselmo; Masamichi Katori; Xiu-Da Shen; Cha πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 454 KB

This study investigated the effects of dual endothelin (ET) receptor blockade in rat models of liver ischemia and reperfusion injury (IRI). Three models of IRI were used: (1) in vivo total hepatic warm ischemia with portal shunting for 60 minutes with control (saline) and treatment groups (15 mg/kg